Murray; Christopher William
Patent Applications and Registrations
Patent applications and USPTO patent grants for Murray; Christopher William.The latest application filed is for "pyrazolyl quinoxaline kinase inhibitors".
Company Profile
7.58.57
- Murray; Christopher William - Cambridge GB
- Murray; Christopher William - Swavesey GB
- Murray, Christopher William - Macclesfield GB
Patent Activity
| Patent | Date |
|---|---|
| Pyrazolyl Quinoxaline Kinase Inhibitors App 20220135544 - SAXTY; Gordon ; et al. | 2022-05-05 |
| Benzolactam compounds as protein kinase inhibitors Grant 11,001,575 - Berdini , et al. May 11, 2 | 2021-05-11 |
| Pyrazolyl Quinoxaline Kinase Inhibitors App 20200131153 - SAXTY; Gordon ; et al. | 2020-04-30 |
| Pyrazolyl quinoxaline kinase inhibitors Grant 10,519,137 - Saxty , et al. Dec | 2019-12-31 |
| Benzolactam compounds as protein kinase inhibitors Grant 10,457,669 - Berdini , et al. Oc | 2019-10-29 |
| Pteridines as FGFR inhibitors Grant 10,272,087 - Saxty , et al. | 2019-04-30 |
| Benzolactam Compounds As Protein Kinase Inhibitors App 20190047990 - BERDINI; Valerio ; et al. | 2019-02-14 |
| Substituted quinoxalines as FGFR kinase inhibitors Grant 10,052,320 - Woodhead , et al. August 21, 2 | 2018-08-21 |
| Pyrazolyl Quinoxaline Kinase Inhibitors App 20180127397 - SAXTY; Gordon ; et al. | 2018-05-10 |
| Hydroxybenzamide derivatives and their use as inhibitors of HSP90 Grant 9,914,719 - Chessari , et al. March 13, 2 | 2018-03-13 |
| Substituted quinoxalines as FGFR kinase inhibitors Grant 9,856,236 - Saxty , et al. January 2, 2 | 2018-01-02 |
| Pyrazolyl quinoxaline kinase inhibitors Grant 9,850,228 - Saxty , et al. December 26, 2 | 2017-12-26 |
| Bicyclic heterocycle compounds and their uses in therapy Grant 9,617,283 - Chessari , et al. April 11, 2 | 2017-04-11 |
| Bicyclic heterocycle compounds and their uses in therapy Grant 9,617,248 - Chessari , et al. April 11, 2 | 2017-04-11 |
| Pteridines As Fgfr Inhibitors App 20170000796 - SAXTY; Gordon ; et al. | 2017-01-05 |
| Pyrazolyl Quinoxaline Kinase Inhibitors App 20160311800 - SAXTY; Gordon ; et al. | 2016-10-27 |
| Pyrazolyl quinoxaline kinase inhibitors Grant 9,464,071 - Saxty , et al. October 11, 2 | 2016-10-11 |
| Pteridines as FGFR inhibitors Grant 9,447,098 - Saxty , et al. September 20, 2 | 2016-09-20 |
| Substitutued Quinoxalines As Fgfr Kinase Inhibitors App 20160220564 - WOODHEAD; Steven John ; et al. | 2016-08-04 |
| Substituted quinoxalines as FGFR kinase inhibitors Grant 9,303,029 - Woodhead , et al. April 5, 2 | 2016-04-05 |
| Substituted quinoxalines as FGFR kinase inhibitors Grant 9,290,478 - Saxty , et al. March 22, 2 | 2016-03-22 |
| Substituted Quinoxalines As Fgfr Kinase Inhibitors App 20160031856 - SAXTY; Gordon ; et al. | 2016-02-04 |
| Bicyclic Heterocycle Compounds And Their Uses In Therapy App 20150353537 - CHESSARI; Gianni ; et al. | 2015-12-10 |
| Pteridines As Fgfr Inhibitors App 20150291589 - Saxty; Gordon ; et al. | 2015-10-15 |
| Bicyclic Heterocycle Compounds And Their Uses In Therapy App 20150259359 - Chessari; Gianni ; et al. | 2015-09-17 |
| Pyrazolyl Quinoxaline Kinase Inhibitors App 20150105368 - SAXTY; Gordon ; et al. | 2015-04-16 |
| Hydroxybenzamide Derivatives And Their Use As Inhibitors Of HSP90 App 20150045362 - Chessari; Gianni ; et al. | 2015-02-12 |
| Anticancer Benzopyrazines Via The Inhibition Of Fgfr Kinases App 20150031669 - Woodhead; Steven John ; et al. | 2015-01-29 |
| Pharmaceutical combinations Grant 8,916,552 - Gallagher , et al. December 23, 2 | 2014-12-23 |
| Pyrazolyl quinoxaline kinase inhibitors Grant 8,895,601 - Saxty , et al. November 25, 2 | 2014-11-25 |
| Bicyclic heterocyclic compounds as FGFR inhibitors Grant 8,895,745 - Berdini , et al. November 25, 2 | 2014-11-25 |
| Pharmaceutical combinations Grant 8,883,790 - Gallagher , et al. November 11, 2 | 2014-11-11 |
| Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors Grant 8,859,582 - Saxty , et al. October 14, 2 | 2014-10-14 |
| Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors Grant 8,859,583 - Saxty , et al. October 14, 2 | 2014-10-14 |
| Hydroxybenzamide derivatives and their use as inhibitors of Hsp90 Grant 8,816,087 - Chessari , et al. August 26, 2 | 2014-08-26 |
| Imidazopyridine derivatives as inhibitors of receptor tyrosine kinases Grant 8,796,244 - Berdini , et al. August 5, 2 | 2014-08-05 |
| Pharmaceutical compounds Grant 8,779,132 - Congreve , et al. July 15, 2 | 2014-07-15 |
| Imidazo [1,2-A]pyridine derivatives as FGFR kinase inhibitors for use in therapy Grant 8,722,687 - Saxty , et al. May 13, 2 | 2014-05-13 |
| Substituted Benzopyrazin Derivatives As Fgfr Kinase Inhibitors For The Treatment Of Cancer Diseases App 20130267525 - Saxty; Gordon ; et al. | 2013-10-10 |
| Therapeutic combinations of hydroxybenzamide derivatives as inhibitors of HSP90 Grant 8,530,469 - Chessari , et al. September 10, 2 | 2013-09-10 |
| Imidazo[1,2-a]pyridine compounds for use in treating cancer Grant 8,513,276 - Berdini , et al. August 20, 2 | 2013-08-20 |
| Pyrazolyl Quinazoline Kinase Inhibitors App 20130072457 - Saxty; Gordon ; et al. | 2013-03-21 |
| Therapeutic Combinations Of Hydroxybenzamide Derivatives As Inhibitors Of HSP90 App 20120251545 - Chessari; Gianni ; et al. | 2012-10-04 |
| Pharmaceutical combinations Grant 8,277,807 - Gallagher , et al. October 2, 2 | 2012-10-02 |
| Imidazopyridine Derivatives As Inhibitors Of Receptor Tyrosine Kinases App 20120208791 - Berdini; Valerio ; et al. | 2012-08-16 |
| FGFR pharmacophore compounds Grant 8,131,527 - Saxty , et al. March 6, 2 | 2012-03-06 |
| Imidazo [1,2-a]pyridine Derivatives As Fgfr Kinase Inhibitors For Use In Therapy App 20120041000 - Saxty; Gordon ; et al. | 2012-02-16 |
| Bicyclic Heterocyclic Compounds As Protein Tyrosine Kinase Inhibitors App 20120035153 - SAXTY; Gordon ; et al. | 2012-02-09 |
| Bicyclic Heterocyclic Compounds As Protein Tyrosine Kinase Inhibitors App 20120035152 - SAXTY; Gordon ; et al. | 2012-02-09 |
| Dihydroxyphenyl isoindolylmethanones Grant 8,106,057 - Chessari , et al. January 31, 2 | 2012-01-31 |
| Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors Grant 8,076,354 - Saxty , et al. December 13, 2 | 2011-12-13 |
| Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors Grant 8,071,614 - Saxty , et al. December 6, 2 | 2011-12-06 |
| Pharmaceutical Combinations App 20110105501 - Gallagher; Neil James ; et al. | 2011-05-05 |
| Meta-benzamidine derivatives as serine protease inhibitors Grant 7,928,137 - Liebeschuetz , et al. April 19, 2 | 2011-04-19 |
| Bicyclic Heterocyclic Compounds As Protein Tyrosine Kinase Inhibitors App 20100331296 - Saxty; Gordon ; et al. | 2010-12-30 |
| Dihydroxyphenyl Isoindolylmethanones App 20100286167 - Chessari; Gianni ; et al. | 2010-11-11 |
| Bicyclic Heterocyclic Compounds As Protein Tyrosine Kinase Inhibitors App 20100286113 - Saxty; Gordon ; et al. | 2010-11-11 |
| Hydroxybenzamide Derivatives And Their Use As Inhibitors Of Hsp90 App 20100216782 - CHESSARI; Gianni ; et al. | 2010-08-26 |
| Pharmaceutical Combinations App 20100179145 - Gallagher; Neil James ; et al. | 2010-07-15 |
| Dihydroxyphenyl isoindolymethanones Grant 7,754,725 - Chessari , et al. July 13, 2 | 2010-07-13 |
| Pharmaceutical Compounds App 20100152184 - Congreve; Miles Stuart ; et al. | 2010-06-17 |
| Bicyclic Heterocyclic Compounds as FGFR Inhibitors App 20100120761 - Berdini; Valerio ; et al. | 2010-05-13 |
| Hydroxybenzamide derivatives and their use as inhibitors of Hsp90 Grant 7,700,625 - Chessari , et al. April 20, 2 | 2010-04-20 |
| Compounds App 20100093718 - Berdini; Valerio ; et al. | 2010-04-15 |
| Pharmaceutical Combinations App 20100092474 - Gallagher; Neil James ; et al. | 2010-04-15 |
| Substituted Amino-Compounds and Uses Thereof App 20090221579 - Albert; Jeffrey Scott ; et al. | 2009-09-03 |
| Pyrimidine Derivatives As HSP90 Inhibitors App 20090215777 - Chessari; Gianni ; et al. | 2009-08-27 |
| Substituted Amino-Pyrimidones and Uses Thereof App 20090062282 - Albert; Jeffrey Scott ; et al. | 2009-03-05 |
| Substituted Aminopyridines and Uses Thereof App 20080287399 - Albert; Jeffrey Scott ; et al. | 2008-11-20 |
| Serine protease inhibitors Grant 7,351,822 - Liebeschuetz , et al. April 1, 2 | 2008-04-01 |
| Hydroxybenzamide Derivatives And Their Use As Inhibitors Of HSP90 App 20070276026 - Chessari; Gianni ; et al. | 2007-11-29 |
| Certain glycine derivatives as factor Xa inhibitors for use in the treatment of thrombotic disorders Grant 7,297,706 - Wiley , et al. November 20, 2 | 2007-11-20 |
| Hydroxybenzamide Derivatives And Their Use As Inhibitors Of HSP90 App 20070259871 - Chessari; Gianni ; et al. | 2007-11-08 |
| Dihydroxyphenyl Isoindolylmethanones App 20070259886 - Chessari; Gianni ; et al. | 2007-11-08 |
| Meta-benzamidine derivatives as serine protease inhibitors App 20070155790 - Liebeschuetz; John Walter ; et al. | 2007-07-05 |
| Meta-benzamidine derivatives as serine protease inhibitors Grant 7,220,781 - Liebeschuetz , et al. May 22, 2 | 2007-05-22 |
| CERTAIN GLYCINE DERIVATIVES AS FACTOR Xa INHIBITORS FOR USE IN THE TREATMENT OF THROMBOTIC DISORDERS App 20070072869 - Wiley; Michael Robert ; et al. | 2007-03-29 |
| Certain glycine derivatives as factor Xa inhibitors for use in the treatment of thrombotic disorders Grant 7,078,415 - Wiley , et al. July 18, 2 | 2006-07-18 |
| Crystals of cytochrome P450 2C9, structures thereof and their use App 20060116826 - Williams; Pamela Ann ; et al. | 2006-06-01 |
| Serine protease inhibitors Grant 7,053,078 - Liebeschuetz , et al. May 30, 2 | 2006-05-30 |
| 3-Hetero arylmethoxy ! pyridines and their analogues as p38 map kinase inhibitors App 20060063782 - Murray; Christopher William ; et al. | 2006-03-23 |
| Serine protease inhibitors Grant 6,946,467 - Liebeschuetz , et al. September 20, 2 | 2005-09-20 |
| Serine protease inhibitors Grant 6,936,611 - Liebeschuetz , et al. August 30, 2 | 2005-08-30 |
| Serine protease inhibitors Grant 6,900,196 - Liebeschuetz , et al. May 31, 2 | 2005-05-31 |
| Serine protease inhibitors Grant 6,878,725 - Liebeschuetz , et al. April 12, 2 | 2005-04-12 |
| Serine protease inhibitors Grant 6,855,715 - Liebeschuetz , et al. February 15, 2 | 2005-02-15 |
| Compounds App 20050032790 - Liebeschuetz, John Walter ; et al. | 2005-02-10 |
| Serine protease inhibitors App 20040259868 - Liebeschuetz, John Walter ; et al. | 2004-12-23 |
| Certain glycine derivatives as factor xa inhibitors for use in the treatment of thrombotic disorders App 20040249155 - Wiley, Michael Robert ; et al. | 2004-12-09 |
| Serine protease inhibitors App 20040242656 - Liebeschuetz, John Walter ; et al. | 2004-12-02 |
| Serine protease inhibitors App 20040176363 - Liebeschuetz, John Walter ; et al. | 2004-09-09 |
| Serine protease inhibitors Grant 6,784,182 - Liebeschuetz , et al. August 31, 2 | 2004-08-31 |
| Serine protease inhibitors App 20040142963 - Liebeschuetz, John Walter ; et al. | 2004-07-22 |
| Meta-benzamidine derivatives as serine protease inhibitors App 20040143018 - Liebeschuetz, John Walter ; et al. | 2004-07-22 |
| Serine pretease inhibitors App 20030109706 - Liebeschuetz, John Walter ; et al. | 2003-06-12 |
| Serine protease inhibitors App 20030078438 - Liebeschuetz, John Walter ; et al. | 2003-04-24 |
| Serine protease inhibitors App 20030055246 - Liebeschuetz, John Walter ; et al. | 2003-03-20 |
| Serine protease inhibitors App 20020151724 - Liebeschuetz, John Walter ; et al. | 2002-10-17 |
| Meta-benzamidine derivatives as serine protease inhibitors App 20020055522 - Liebeschuetz, John Walter ; et al. | 2002-05-09 |
| 1-amino-7-isoquinoline derivatives as serine protease inhibitors App 20020040144 - Liebeschuetz, John Walter ; et al. | 2002-04-04 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 